1-20 of 250
thrombopoietin receptor agonists
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Clinical Trials & Observations
Francesca Palandri, Elena Rossi, Daniela Bartoletti, Antonietta Ferretti, Marco Ruggeri, Elisa Lucchini, Valentina Carrai, Wilma Barcellini, Andrea Patriarca, Elena Rivolti, Ugo Consoli, Silvia Cantoni, Esther Natalie Oliva, Federico Chiurazzi, Giovanni Caocci, Gaetano Giuffrida, Alessandra Borchiellini, Giuseppe Auteri, Erminia Baldacci, Giuseppe Carli, Daniela Nicolosi, Emanuele Sutto, Monica Carpenedo, Michele Cavo, Maria Gabriella Mazzucconi, Francesco Zaja, Valerio De Stefano, Francesco Rodeghiero, Nicola Vianelli
Journal: Blood
Blood (2021) 138 (7): 571–583.
https://doi.org/10.1182/blood.2021010735
Published: 2021
Includes: Supplemental data
Journal Articles

Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study

Maria Luisa Lozano, MD PhD, Maria Eva Mingot-Castellano, PhD MD, María Perera, MD, Isidro Jarque, Rosa Maria Campos, Tomás José González-López, MD, Gonzalo Carreño Gomez-Tarragona, Nuria Bermejo, MD, Maria Fernanda Lopez Fernandez, Aurora de Andrés, David Valcarcel, Felipe Casado, Teresa Álvarez Roman, María Isabel Orts, MD, Silvana Novelli, MD, Jose Ramon González-Porras, MD PhD, Estefanía Bolaños, Manuel Rodríguez López, MD, Elisa Orna, Vicente Vicente Garcia, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1088.
https://doi.org/10.1182/blood-2019-125557
Published: 2019
Journal Articles

Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry

Aurélien Sokal, Thomas de Nadaï, Thibault Comont, Nicolas Limal, Marc Michel, Odile Beyne-Rauzy, Bertrand Godeau, MD, Daniel Adoue, Matthieu Mahévas, Guillaume Moulis, MD PhD, Carmen investigators Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 1091.
https://doi.org/10.1182/blood-2019-126019
Published: 2019
Journal Articles

A Systematic Review and Meta-Analysis of Safety and Efficacy for Pre-Procedural Use of Thrombopoietin Receptor Agonists in Hepatic Cirrhosis Patients

Kunhwa Kim, MDMPH, Faustine Ong, Gabor Varadi, MD, Sorab Gupta, MD, Vinicius Machado Jorge, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1094.
https://doi.org/10.1182/blood-2019-132063
Published: 2019
Journal Articles

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Waleed Ghanima, MD PhD, Tjønnfjord Eirik, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4901.
https://doi.org/10.1182/blood-2019-128359
Published: 2019
Journal Articles

Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience

Hasmik Nazaryan, Yang Liu, MS, Emily Sirotich, BS, Joanne M Duncan, MSc, Donald M. Arnold, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2120.
https://doi.org/10.1182/blood-2019-128336
Published: 2019
Journal Articles

Romiplostim Improves Platelet Recovery after UCB Transplant

Georgios E. Christakopoulos, MD, Todd E. DeFor, MS, Stefanie M Hage, RN, John E. Wagner, MD, Michael A. Linden, MD PhD, Claudio G Brunstein, MD PhD, Nelli Bejanyan, MD, Michael R Verneris, MD, Angela R. Smith, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1979.
https://doi.org/10.1182/blood-2019-125424
Published: 2019
Journal Articles

Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

Lee F. Allen, MD PhD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Christine Barnett, PhD, Deirdre Mladsi, BA, Ray Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3454.
https://doi.org/10.1182/blood-2019-131822
Published: 2019
Journal Articles

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Esther Natalie Oliva, MD, Caterina Alati, MD, Valeria Santini, MD, Antonella Poloni, PhD MD, Marta Riva, MD, Pasquale Niscola, MD PhD, Valentina Giai, MD, Grazia Sanpaolo, MD, Enrico Balleari, Elena Crisà, MD, Dario Ferrero, MD, Ulrich Germing, MD, Pierre Fenaux, MD PhD, Giuseppe A. Palumbo, MD PhD, Prassede Salutari, MD, Stefana Impera, MD, Isabella Capodanno, MD, Gianluigi Reda, MD, Anna Marina Liberati, Alfredo Molteni, MD, Giorgina Specchia, MD, Francesco Buccisano, MD, Maria Teresa Voso, MD, Stefano Mancini, MD, Monica Bocchia, Anna Candoni, MD, Bruno Martino, MD, Patrizia Cufari, Maria Grazia D'Errigo, Gina Zini, MD PhD, Roberto Latagliata
Journal: Blood
Blood (2019) 134 (Supplement_1): 3000.
https://doi.org/10.1182/blood-2019-126744
Published: 2019
Journal Articles

Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network

Uwe Platzbecker, MD, Anne Sophie Kubasch, MD, Aristoteles Giagounidis, MD, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Borhane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, MSc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, MD, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2998.
https://doi.org/10.1182/blood-2019-129047
Published: 2019
Journal Articles

Long-Term Response Rates in Patients with Chronic Immune Thrombocytopenia Treated with Avatrombopag: Additional Analyses from a Phase 3 Study and Its Extension Phase

Hanny Al-Samkari, MD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Wei Tian, PhD, Lee F. Allen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2356.
https://doi.org/10.1182/blood-2019-131215
Published: 2019
Journal Articles

Outcomes in Pediatric Patients with Severe Aplastic Anemia Treated with Standard Immunosuppression and Eltrombopag

Emma M. Groarke, MD, Bhavisha A Patel, MD, Carrie Diamond, MD, Fernanda Gutierrez-Rodrigues, PhD, Alana Vicente, MD, Olga Rios, RN, Jennifer Lotter, PA-C, Daniela Baldoni, Ruba Shalhoub, Colin Wu, PhD, Neal S. Young, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 454.
https://doi.org/10.1182/blood-2019-124811
Published: 2019
Journal Articles

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies

Hanny Al-Samkari, MD, Aric D Parnes, MD, Katayoon Goodarzi, MD, James I Weitzman, MD, Jean M. Connors, MD, David J. Kuter
Journal: Blood
Blood (2019) 134 (Supplement_1): 389.
https://doi.org/10.1182/blood-2019-123864
Published: 2019
Journal Articles

Temporal Trends of Intracranial Hemorrhage Among Immune Thrombocytopenia Hospitalizations in the United States from 2007-2016

Mayank Sharma, Parth Bhatt, Marian Ayensu, Kuhoo Bhal, Fredrick Dapaah-Siakwan, MD, Keyur Donda, Helen Oletu, Priyank Yagnik, MD, Neel S Bhatt, MBBS,MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 55.
https://doi.org/10.1182/blood-2019-132102
Published: 2019
Journal Articles

Comparing the Risk of Complications for Second-Line Treatments of Immune Thrombocytopenia in Veterans: A U.S. National Study

Natalia Ruiz-Negron, PharmD, Jacob Crook, MStat, Matthew T. Rondina, MD, Pallavi Patwardhan, PhD, Qayyim Said, PhD, Isha Desai, MPH, Richard Nelson, PhD, Joanne LaFleur, PharmD, MSPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 85.
https://doi.org/10.1182/blood-2019-121894
Published: 2019
Journal Articles

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

David J. Kuter, Ralph V. Boccia, MD, Eun-Ju Lee, MD, Merlin Efraim, MD, Nikolay Tzvetkov, MD, Jiri Mayer, MD, Marek Trněný, MD, Milan Kostal, MD, Roman Hajek, MD, Vickie McDonald, MD, Olga Bandman, MD, Regan Burns, Ann Neale, Dolca Thomas, MD, Nichola Cooper, MD MRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 87.
https://doi.org/10.1182/blood-2019-122336
Published: 2019
Journal Articles

Long-Term Durability of Eltrombopag Clinical Benefit for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia (ASPIRE Part 3)

Moshe Mittelman, MD, Uwe Platzbecker, MD, Boris Afanasyev, MD PhD, Sebastian Grosicki, MD PhD, Maria Socorro O Portella, MD MBA, Zewen Zhu, Dominik Selleslag, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3740.
https://doi.org/10.1182/blood-2019-130309
Published: 2019
Journal Articles

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Mohsen Saleh Elalfy, MD, Tamer Hassan, MD, Khalid Elsayh, MD, Mohamed Maebid, MD, Hoda Hassab, MD, Rasha Elashry, MD, Mona El ghamrawy, MD, Mahmoud Elhawy, MD, Marwa Zakaria, MD, Mohamed Elshanshory, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4907.
https://doi.org/10.1182/blood-2019-121994
Published: 2019
Journal Articles

Outcome of Standard Immunosuppressive Therapy with or without Eltrombopag for Chinese Patients with Severe Aplastic Anemia in the Real World

Jinsong JIA, MD PhD, Hao Jiang, Xiao Jun Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5019.
https://doi.org/10.1182/blood-2019-131670
Published: 2019
Journal Articles

Eltrombopag Treatment for Patients with Thrombocytopenia Post-Transplantation Showed a Good Chance of Platelet Recovery

Fei Gao, MD, Yanmin Zhao, MD, He Huang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5658.
https://doi.org/10.1182/blood-2019-125759
Published: 2019